SymBio Pharmaceuticals Limited (4582.T) - Stock Prices, Stock Peers & Analysis

Home
4582.T

Company Name	SymBio Pharmaceuticals Limited
Symbol	4582.T
Currency	JPY
Price	249
Market Cap Market Cap The market capitalization (market cap) of a stock represents the total market value of a company's outstanding shares of stock. It's a key metric used to gauge a company's size and investment risk, and it can be an important factor in investment decisions. Here's how it's calculated: Market Cap = Number of Outstanding Shares × Current Share Price	11,409,333,384
Dividend Yield Dividend Yield The dividend yield is a financial ratio that measures the amount of cash dividends distributed to common shareholders relative to the market value per share. The dividend yield is represented as a percentage and can be calculated by dividing the dollar value of dividends paid in a given year per share of stock held by the dollar value of one share of stock. Here's how it's calculated: Dividend Yield = Annual Dividends per Share / Price per Share	0%
52-week-range	146 - 475
Industry	Drug Manufacturers—Specialty & Generic
Sector	Healthcare
CEO	Mr. Fuminori Yoshida
Website	https://www.symbiopharma.com

An error occurred while fetching data.

About SymBio Pharmaceuticals Limited

SymBio Pharmaceuticals Limited engages in the research and development, manufacturing, and marketing of pharmaceutical drugs in the areas of oncology and hematology in Japan. It is involved in the development of Treakisym SyB L-0501, an anti-cancer agent, which is marketed for the treatment of non-Hodgkin's lymphoma, multiple myeloma, and chronic